Ticker
$CEROW
1 catalyst touching CEROW in the last 60 days, newest first, each with the price move that followed.
- 72
CEROW to sell subsidiary to SRX Global for stock and debt relief
CEROW signed a definitive Stock Purchase Agreement to sell its operating subsidiary CERo Therapeutics, Inc. to SRX Global Inc. in exchange for approximately $1M in SRX stock, forgiveness of ~$8.2M in outstanding debt, assumption of ~$1.6M in liabilities, and extended debt maturity. The deal includes a 30-day go-shop period and Superior Proposal rights, meaning the transaction is not yet locked and the board retains flexibility to pursue alternative bids, which creates uncertainty about final outcome and pricing.
CEROW ·SEC 8-K · 7 Oct 2026, 12:30 UTC
Information only. AURA does not give buy or sell recommendations.